A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer (MRFF EPCDR administered by Griffith). (2020–2024)
- Grant type:
- Griffith University
- Researchers:
-
-
NHMRC Leadership Fellow
UQ Centre for Clinical ResearchFaculty of Medicine -
-
-
- Funded by:
- Griffith University
